Peramivir Inhalation Solution (广州南鑫药业)

帕拉米韦吸入溶液 (广州南鑫药业)

Report date: 2026/05/12 20:00:17

Base Information

Drug NamePeramivir Inhalation Solution (广州南鑫药业)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsHeadacheFatigue +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGuangzhou Nanxin Pharma Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsHeadacheFatigue +[9
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A